As depicted in Figure 7A, TETs expression exhibited a significant positive correlation with pan-cancer immune subtypes (p < 0.05): notably, TET1 and TET2 were markedly upregulated in immune subtype C5, whereas their expression remained stable in other subtypes; TET3 displayed variable expression levels across immune subtypes. The gene discussed is TET3; the disease is cancer.